Core Viewpoint - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the securities class action is from February 27, 2023, to November 4, 2025 [2]. - Investors who purchased Perrigo securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by January 16, 2026 [4]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [5]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including underinvestment in maintenance and significant manufacturing deficiencies [6]. - It is claimed that Perrigo's financial results were overstated due to these issues, leading to misleading positive statements about the company's operations and prospects [6].

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Perrigo's acquisition of the infant formula business from Nestlé was significantly underinvested in maintenance and operational improvements [2]. - It is alleged that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated cost estimates to address issues in the infant formula business [2]. - The complaint points out significant manufacturing deficiencies in the facility dedicated to the infant formula business [2]. - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were reportedly overstated [2]. - The positive statements made by the defendants regarding the Company's business and prospects were claimed to be materially misleading and lacked a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until January 16, 2026, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Perrigo Company plc regarding a class action lawsuit due to alleged misleading statements and operational deficiencies related to the company's infant formula business [2][4]. Summary by Relevant Sections Allegations - The complaint alleges that during the class period from February 27, 2023, to November 4, 2025, Perrigo made materially false and misleading statements and failed to disclose significant issues, including: 1. The infant formula business acquired from Nestlé suffered from underinvestment in maintenance and operational improvements [2]. 2. Perrigo needed to incur substantial capital and operational expenditures beyond previously stated estimates to remediate the infant formula business [2]. 3. There were significant manufacturing deficiencies in the facility for the infant formula business [2]. 4. As a result, the company's financial results, including earnings and cash flow, were overstated [2]. 5. The positive statements made by defendants regarding the company's business and prospects were materially misleading and lacked a reasonable basis [2]. Next Steps for Shareholders - Shareholders who purchased shares of PRGO during the specified timeframe are encouraged to register for the class action by January 16, 2026, to potentially be appointed as lead plaintiff [3]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case [3]. Law Firm's Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights and ensuring companies adhere to responsible business practices [4].

Core Insights - Meridian Contrarian Fund reported a 6.72% net return in Q3 2025, underperforming the Russell 2500 Index which returned 9.00% and the Russell 2500 Value Index at 8.18% [1] - The fund's performance was influenced by record high equities, driven by technology gains and falling bond yields, alongside easing tariff rhetoric and renewed AI infrastructure investments [1] Company Analysis: Perrigo Company plc (NYSE:PRGO) - Perrigo Company plc is a leading provider of over-the-counter health and wellness solutions, but its stock has faced significant declines, with a one-month return of -34.97% and a 52-week loss of 53.13% [2] - As of November 28, 2025, Perrigo's stock closed at $13.35, with a market capitalization of $1.837 billion [2] - The company has struggled with declining earnings due to poor capital allocation by previous management, which focused on acquisitions outside its core business [3] - A new management team is now focused on realistic growth within the core business, aiming for improved profitability and returns on capital [3] - Despite recent underperformance, the company continues to be held in the fund's portfolio, although earnings guidance has been lowered due to challenges in the recovering infant formula business [3] Investment Sentiment - Perrigo Company plc is not among the 30 most popular stocks among hedge funds, with 22 hedge fund portfolios holding the stock at the end of Q3 2025, unchanged from the previous quarter [4] - While acknowledging Perrigo's potential, the fund suggests that certain AI stocks may offer greater upside potential and less downside risk [4]

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding the financial health of its infant formula business acquired from Nestlé [1][3]. Group 1: Class Action Details - The class action lawsuit is titled French v. Perrigo Company plc and covers securities purchases made between February 27, 2023, and November 4, 2025, with a deadline for lead plaintiff applications set for January 16, 2026 [1][8]. - The lawsuit alleges that Perrigo's acquisition of Nestlé's Gateway infant formula plant for $170 million was marred by significant underinvestment and operational deficiencies [2][3]. Group 2: Financial Implications - On February 27, 2024, Perrigo disclosed acquisition-related charges of $35 million to $45 million for remediation efforts, alongside a 50% decline in earnings per share compared to the previous year, leading to a stock price drop of over 15% [4]. - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, and a gross margin decline of 90 basis points, resulting in a nearly 10% drop in stock price [5]. - On August 6, 2025, Perrigo's adjusted gross profit decreased by $30 million (6.9%), with a reported gross margin of 34.4%, causing an over 11% decline in stock price [6]. - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, slashing its fiscal year 2025 outlook, which included a negative sales growth guidance of -2.5% to -3% and a significant cut in expected earnings per share, leading to a stock price drop of over 25% [7].

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for alleged violations of securities laws, specifically related to misleading statements made after its acquisition of Nestlé's baby formula business [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from February 27, 2025, to November 4, 2025, with a deadline for lead plaintiff appointments set for January 16, 2026 [2]. - The complaint alleges that Perrigo made false and misleading statements regarding the condition of the acquired business, which required significant investments for maintenance and repairs [2]. Group 2: Investor Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although this is not necessary to participate in any recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress at no cost [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [2][3]. Group 1: Class Action Details - The class period for the securities class action is from February 27, 2023, to November 4, 2025, inclusive [2]. - Investors who purchased Perrigo securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by January 16, 2026 [4]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its success in securities class action settlements [5]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including issues related to underinvestment, necessary capital expenditures, and manufacturing deficiencies [6]. - As a result of these misstatements, Perrigo's financial results were overstated, leading to investor damages when the true information became public [6].

Core Viewpoint - Perrigo Company is facing a class action lawsuit due to allegations of misleading investors about the value of its infant formula business, which has resulted in significant financial repercussions for the company [1][3]. Summary by Sections Company Overview - Perrigo Company (NYSE: PRGO) provides over-the-counter health and wellness solutions in the U.S., Europe, and internationally [1]. Class Action Details - The class period for the lawsuit is from February 27, 2024, to November 4, 2025 [1]. - The lawsuit was filed by Robbins LLP on behalf of all investors who acquired Perrigo securities during the class period [1]. Allegations Against Perrigo - The complaint alleges that Perrigo failed to disclose several critical issues regarding its infant formula business: 1. Significant underinvestment in maintenance, operational improvements, and repairs [3]. 2. The need for substantial capital and operational expenditures beyond previously stated cost estimates to remediate the business [3]. 3. Significant manufacturing deficiencies in the infant formula facility [3]. 4. Overstated financial results, including earnings and cash flow, due to the above issues [3]. Financial Impact - On November 5, 2025, Perrigo announced disappointing financial results for Q3 2025, leading to a reduction in its fiscal year 2025 outlook primarily due to dynamics in the infant formula industry [4]. - The company is initiating a strategic review of its infant formula business and reassessing a previously announced investment of $240 million, indicating that the business has become "less strategic" [4]. - Following this announcement, Perrigo's stock price fell by $5.09, or 25.2%, closing at $15.10 per share on November 5, 2025 [4].

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for allegedly misleading investors regarding its financial health and operations, particularly related to its infant formula business acquired from Nestlé [5]. Group 1: Lawsuit Details - The class action lawsuit pertains to securities purchased between February 27, 2023, and November 4, 2025, and aims to address claims of materially false and misleading statements made by the defendants [1][5]. - Key allegations include significant underinvestment in the infant formula business, the need for substantial capital expenditures beyond stated estimates, and manufacturing deficiencies that led to overstated financial results [5]. Group 2: Investor Actions - Investors who purchased Perrigo securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by submitting a form or contacting the law firm directly, with a deadline to serve as lead plaintiff set for January 16, 2026 [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm emphasizes the importance of selecting qualified legal counsel with proven success in similar cases to represent investors effectively [4].

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for alleged violations of securities laws, specifically related to misleading statements made after its acquisition of Nestlé's baby formula business [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from February 27, 2025, to November 4, 2025, with a deadline for lead plaintiff appointments set for January 16, 2026 [2]. - The complaint alleges that Perrigo made false and misleading statements regarding the condition of the acquired business, which suffered from significant underinvestment in maintenance and repairs, leading to substantial remedial investments by the company [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although this is not a requirement for recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress, with no associated costs or obligations [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4]. - The firm represents large hedge funds and alternative asset managers, emphasizing the value of litigation claims as significant assets [4].